Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Early weight gain predicting later weight gain among depot medroxyprogesterone acetate users.

Le YC, Rahman M, Berenson AB.

Obstet Gynecol. 2009 Aug;114(2 Pt 1):279-84. doi: 10.1097/AOG.0b013e3181af68b2.

2.

Early weight gain related to later weight gain in adolescents on depot medroxyprogesterone acetate.

Bonny AE, Secic M, Cromer B.

Obstet Gynecol. 2011 Apr;117(4):793-7. doi: 10.1097/AOG.0b013e31820f387c.

3.

Body weight and body composition of depot medroxyprogesterone acetate users.

Dal'Ava N, Bahamondes L, Bahamondes MV, Bottura BF, Monteiro I.

Contraception. 2014 Aug;90(2):182-7. doi: 10.1016/j.contraception.2014.03.011. Epub 2014 Mar 27.

PMID:
24780631
4.

Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.

Polaneczky M, Guarnaccia M, Alon J, Wiley J.

Fam Plann Perspect. 1996 Jul-Aug;28(4):174-8.

PMID:
8853283
5.

Body composition and weight gain in new users of the three-monthly injectable contraceptive, depot-medroxyprogesterone acetate, after 12 months of follow-up.

dos Santos Pde N, Modesto WO, Dal'Ava N, Bahamondes MV, Pavin EJ, Fernandes A.

Eur J Contracept Reprod Health Care. 2014 Dec;19(6):432-8. doi: 10.3109/13625187.2014.936934. Epub 2014 Jul 22.

PMID:
25047227
6.

Weight gain, adiposity, and eating behaviors among adolescent females on depot medroxyprogesterone acetate (DMPA).

Bonny AE, Britto MT, Huang B, Succop P, Slap GB.

J Pediatr Adolesc Gynecol. 2004 Apr;17(2):109-15.

PMID:
15050987
7.

Dietary Intake and Weight Gain Among Adolescents on Depot Medroxyprogesterone Acetate.

Lange HL, Belury MA, Secic M, Thomas A, Bonny AE.

J Pediatr Adolesc Gynecol. 2015 Jun;28(3):139-43. doi: 10.1016/j.jpag.2014.04.004. Epub 2014 May 5.

8.

Weight change at 12 months in users of three progestin-only contraceptive methods.

Vickery Z, Madden T, Zhao Q, Secura GM, Allsworth JE, Peipert JF.

Contraception. 2013 Oct;88(4):503-8. doi: 10.1016/j.contraception.2013.03.004. Epub 2013 Mar 18.

9.

Weight and body fat changes in postpartum depot-medroxyprogesterone acetate users.

Nyirati CM, Habash DL, Shaffer LE.

Contraception. 2013 Jul;88(1):169-76. doi: 10.1016/j.contraception.2012.10.016. Epub 2012 Nov 21.

PMID:
23177262
10.

Insulin resistance parameters in users of the injectable contraceptive depot medroxyprogesterone acetate during one year of use.

Cursino K, Sider M, Pavin EJ, dos Santos Pde N, Bahamondes L, Zantut-Wittmann DE, Fernandes A.

Eur J Contracept Reprod Health Care. 2016;21(1):22-9. doi: 10.3109/13625187.2015.1059415. Epub 2015 Jul 3.

PMID:
26140543
11.

Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.

Taneepanichskul S, Intaraprasert S, Theppisai U, Chaturachinda K.

Contraception. 1997 Jul;56(1):1-3.

PMID:
9306024
12.

Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.

Piya-Anant M, Koetsawang S, Patrasupapong N, Dinchuen P, d'Arcangues C, Piaggio G, Pinol A.

Contraception. 1998 Jan;57(1):23-8.

PMID:
9554247
13.

Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use.

Berenson AB, Rahman M.

Am J Obstet Gynecol. 2009 Mar;200(3):329.e1-8. doi: 10.1016/j.ajog.2008.12.052.

14.

Depressive symptoms in users and non-users of depot medroxyprogesterone acetate.

Civic D, Scholes D, Ichikawa L, LaCroix AZ, Yoshida CK, Ott SM, Barlow WE.

Contraception. 2000 Jun;61(6):385-90.

PMID:
10958882
15.

Depo Provera. Position paper on clinical use, effectiveness and side effects.

Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.

Br J Fam Plann. 1999 Jul;25(2):69-76. Review. Erratum in: Br J Fam Plann 2000 Jan;26(1):52-3.

PMID:
10454658
16.

Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate.

Mangan SA, Larsen PG, Hudson S.

J Pediatr Adolesc Gynecol. 2002 Apr;15(2):79-82.

PMID:
12057528
17.

Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.

Clark MK, Sowers MR, Nichols S, Levy B.

Fertil Steril. 2004 Dec;82(6):1580-6.

PMID:
15589863
18.

A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.

Viola AS, Castro S, Bahamondes MV, Fernandes A, Viola CF, Bahamondes L.

Contraception. 2011 Nov;84(5):e31-7. doi: 10.1016/j.contraception.2011.06.012. Epub 2011 Aug 10.

PMID:
22018135
19.

Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture.

Lanza LL, McQuay LJ, Rothman KJ, Bone HG, Kaunitz AM, Harel Z, Ataher Q, Ross D, Arena PL, Wolter KD.

Obstet Gynecol. 2013 Mar;121(3):593-600. doi: 10.1097/AOG.0b013e318283d1a1.

PMID:
23635623
20.

Predictors of higher bone mineral density loss and use of depot medroxyprogesterone acetate.

Rahman M, Berenson AB.

Obstet Gynecol. 2010 Jan;115(1):35-40. doi: 10.1097/AOG.0b013e3181c4e864.

Supplemental Content

Support Center